[Epoietins (EPO)].
Taeron
Corinne
C
D000068256:Darbepoetin alfa; D016903:Drug Monitoring; D000068817:Epoetin Alfa; D004921:Erythropoietin / Q000009:adverse effects / Q000031:analogs & derivatives / Q000600:supply & distribution / Q000627:therapeutic use*; D005602:France; D006397:Hematinics / Q000009:adverse effects / Q000600:supply & distribution / Q000627:therapeutic use*; D006801:Humans; D024802:Nurse's Role; D010353:Patient Education as Topic; D018579:Patient Selection; D011994:Recombinant Proteins
D006397:Hematinics; D011994:Recombinant Proteins; C103998:epoetin beta; D004921:Erythropoietin; D000068256:Darbepoetin alfa; D000068817:Epoetin Alfa